| DC Field | Value | Language |
|---|
| dc.contributor.author | Klycheva, O. I. | - |
| dc.contributor.author | Lazareva, G. A. | - |
| dc.contributor.author | Khuraseva, A. B. | - |
| dc.date.accessioned | 2022-04-22T05:08:26Z | - |
| dc.date.available | 2022-04-22T05:08:26Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Klycheva, O.I. Pharmacological correction of fetoplacental insufficiency with fetal growth retardation syndrome / O.I. Klycheva, G.A. Lazareva, A.B. Khuraseva // Research Result: Pharmacology and Clinical Pharmacology. - 2017. - Vol. 3, № 2.- P. 64-78. - DOI: 10.18413/2313-8971-2017-3-2-64-78. - Refer.: p. 77-78 | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46288 | - |
| dc.description.abstract | The aim of the study was to compare the pharmacological effectiveness of commonly used angioprotective agents "Pentoxifylline"®, "Phlebodia 600",® and "Curantil 25"® based on the results of laboratory and instrumental methods of research conducted after treatment. The retrospective and prospective survey of 120 pregnant women with 28-36 weeks of gestation were carried out on a clinical site of the Department of Obstetrics and gynecology of KSMU, and on the site of the Regional Perinatal Center of the City of Kursk | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | fetoplacental insufficiency | ru |
| dc.subject | fetal growth retardation syndrome | ru |
| dc.subject | Flebodia 600 | ru |
| dc.subject | Curantil 25 | ru |
| dc.subject | Pentoxifylline | ru |
| dc.subject | angioprotectors | ru |
| dc.subject | microcirculation | ru |
| dc.title | Pharmacological correction of fetoplacental insufficiency with fetal growth retardation syndrome | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 3, № 2
|
